Grayling Blog
Interest in Pharma to the Russian Market
Posted on 23.04.2011 by Pavel Melnikov
The last couple of years marked an increasing interest from Big Pharma to the Russian market. Here and there, companies report either acquisitions of a Russian company or plans to build their own plants from scratch in one of the regions. Vladimir Shipkov, Head of the Association of International Pharma…
1 result found